Bako Diagnostics

Bako Diagnostics operates as a laboratory services provider, delivering diagnostic testing services to healthcare clients and patients. The organisation is headquartered in the United States, with its operations based in the state of Georgia. It performs a range of clinical laboratory analyses that support medical decision‑making and patient care. Its services are utilized by healthcare providers who rely on accurate test results for diagnosis and treatment planning. By handling specimens and generating reports, Bako Diagnostics contributes to the broader healthcare delivery system. The company’s activities involve the collection, processing, and interpretation of biological samples for various medical specialties.

Bako Diagnostics handles protected health information as part of its laboratory workflow, placing it under the regulatory requirements of HIPAA. The 2021 cyberattack incident highlighted its responsibility to safeguard sensitive patient data, including names, contact details, health insurance information, medical records, and financial identifiers. Following the breach affecting 25,745 individuals, the organisation implemented enhanced security measures and system hardening. It also offered complimentary credit monitoring to those whose Social Security numbers were exposed. No explicit details about ownership, parent or subsidiary relationships, or overall size are provided in the available sources. Consequently, the profile focuses solely on the confirmed aspects of its service scope, geographic base, and regulatory context.